Bariatric surgery emerges as the most effective long-term intervention for obesity, not only through anatomical changes but also by inducing favorable hormonal shifts—particularly increased levels of GLP-1 and PYY—that enhance satiety and improve glucose metabolism. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.